Amicus Therapeutics, Inc. (FOLD) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 185.21M | 169.06M | 154.69M | 125.25M | 149.71M | 141.52M | 126.67M | 110.4M | 115.08M | 103.5M | 94.5M | 86.27M |
| Revenue Growth % | 23.72% | 19.46% | 22.12% | 13.45% | 30.09% | 36.73% | 34.04% | 27.97% | 30.63% | 26.7% | 17.06% | 9.6% |
| Cost of Goods Sold | 28.44M | 21.34M | 15.22M | 11.7M | 14.84M | 13.28M | 11.26M | 13.57M | 11.32M | 9.95M | 9.11M | 6.94M |
| COGS % of Revenue | 15.36% | 12.62% | 9.84% | 9.34% | 9.91% | 9.38% | 8.89% | 12.29% | 9.84% | 9.61% | 9.64% | 8.05% |
| Gross Profit | 156.77M | 147.72M | 139.47M | 113.55M | 134.87M | 128.24M | 115.41M | 96.84M | 103.76M | 93.56M | 85.39M | 79.33M |
| Gross Margin % | 84.64% | 87.38% | 90.16% | 90.66% | 90.09% | 90.62% | 91.11% | 87.71% | 90.16% | 90.39% | 90.36% | 91.95% |
| Gross Profit Growth % | 16.24% | 15.19% | 20.85% | 17.26% | 29.99% | 37.07% | 35.16% | 22.07% | 31.82% | 37.07% | 17.72% | 11.52% |
| Operating Expenses | 140.82M | 113.45M | 148.94M | 121.5M | 118.9M | 106.58M | 100.44M | 124.56M | 107.45M | 110.58M | 104.25M | 116.96M |
| OpEx % of Revenue | 76.03% | 67.11% | 96.29% | 97.01% | 79.42% | 75.31% | 79.29% | 112.82% | 93.37% | 106.84% | 110.31% | 135.58% |
| Selling, General & Admin | 117.08M | 90.04M | 84.54M | 91.83M | 86.67M | 75.11M | 73.58M | 88.03M | 70.24M | 65.65M | 65.42M | 73.96M |
| SG&A % of Revenue | 63.21% | 53.26% | 54.65% | 73.32% | 57.89% | 53.07% | 58.09% | 79.73% | 61.03% | 63.43% | 69.23% | 85.73% |
| Research & Development | 23.74M | 23.41M | 60.85M | 27.84M | 30.19M | 26.16M | 24.68M | 28.33M | 35.03M | 40.7M | 35.15M | 41.5M |
| R&D % of Revenue | 12.82% | 13.85% | 39.34% | 22.23% | 20.17% | 18.49% | 19.49% | 25.66% | 30.44% | 39.33% | 37.19% | 48.1% |
| Other Operating Expenses | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 15.95M | 34.27M | -9.47M | -7.95M | 15.97M | 21.66M | 14.97M | -27.72M | -3.69M | -17.02M | -18.86M | -37.64M |
| Operating Margin % | 8.61% | 20.27% | -6.12% | -6.35% | 10.67% | 15.3% | 11.82% | -25.11% | -3.21% | -16.45% | -19.96% | -43.63% |
| Operating Income Growth % | -0.16% | 58.22% | -163.3% | 71.31% | 532.58% | 227.23% | 179.36% | 26.34% | 91.28% | 49.7% | 68.88% | 50.04% |
| EBITDA | 17.84M | 36.14M | -7.62M | -6.12M | 18.01M | 23.83M | 17.15M | -25.57M | -1.51M | -14.79M | -16.65M | -36.38M |
| EBITDA Margin % | 9.63% | 21.38% | -4.93% | -4.88% | 12.03% | 16.84% | 13.54% | -23.16% | -1.31% | -14.29% | -17.62% | -42.17% |
| EBITDA Growth % | -0.94% | 51.68% | -144.45% | 76.08% | 1292.85% | 261.06% | 202.97% | 29.72% | 96.32% | 54.55% | 71.91% | 50.79% |
| D&A (Non-Cash Add-back) | 1.9M | 1.87M | 1.85M | 1.84M | 2.04M | 2.17M | 2.18M | 2.15M | 2.18M | 2.23M | 2.21M | 1.26M |
| EBIT | 14.57M | 45.98M | -7.62M | -6.59M | 19.89M | 19.48M | 12.62M | -31.15M | -18.83M | -11.72M | -28.02M | -41.38M |
| Net Interest Income | -10.6M | -10.88M | -10.72M | -10.64M | -10.54M | -11.61M | -11.14M | -10.9M | -11.16M | -11.52M | -10.76M | -9.64M |
| Interest Income | 833K | 829K | 843K | 812K | 1.42M | 1.08M | 1.37M | 1.54M | 1.67M | 1.47M | 1.74M | 2.2M |
| Interest Expense | 11.43M | 11.71M | 11.56M | 11.46M | 11.96M | 12.69M | 12.51M | 12.44M | 12.83M | 12.99M | 12.49M | 11.84M |
| Other Income/Expense | -12.8M | 5K | -9.71M | -10.09M | -8.04M | -14.87M | -14.86M | -15.86M | -27.97M | -7.68M | -21.66M | -15.58M |
| Pretax Income | 3.14M | 34.27M | -19.18M | -18.05M | 7.93M | 6.79M | 108K | -43.58M | -31.66M | -24.7M | -40.52M | -53.22M |
| Pretax Margin % | 1.7% | 20.27% | -12.4% | -14.41% | 5.3% | 4.79% | 0.09% | -39.48% | -27.51% | -23.87% | -42.87% | -61.69% |
| Income Tax | 1.45M | 16.97M | 5.24M | 3.64M | -6.8M | 13.51M | 15.8M | 4.84M | 2.18M | -3.13M | 2.71M | -287K |
| Effective Tax Rate % | 46.23% | 49.51% | -27.31% | -20.18% | -85.77% | 199.17% | 14634.26% | -11.1% | -6.9% | 12.66% | -6.7% | 0.54% |
| Net Income | 1.69M | 17.31M | -24.42M | -21.69M | 14.74M | -6.73M | -15.7M | -48.42M | -33.84M | -21.58M | -43.23M | -52.93M |
| Net Margin % | 0.91% | 10.24% | -15.79% | -17.31% | 9.85% | -4.75% | -12.39% | -43.86% | -29.41% | -20.85% | -45.75% | -61.36% |
| Net Income Growth % | -88.53% | 357.19% | -55.57% | 55.21% | 143.55% | 68.81% | 63.69% | 8.53% | 39.42% | 35.18% | 30.45% | 37.92% |
| Net Income (Continuing) | 1.69M | 17.31M | -24.42M | -21.69M | 14.74M | -6.73M | -15.7M | -48.42M | -33.84M | -21.58M | -43.23M | -52.93M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.01 | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 | -0.05 | -0.16 | -0.12 | -0.07 | -0.15 | -0.18 |
| EPS Growth % | -89.05% | 379% | -60% | 56.25% | 142.76% | 71.43% | 66.67% | 11.11% | 41.97% | 41.67% | 28.57% | 40% |
| EPS (Basic) | 0.01 | 0.06 | -0.08 | -0.07 | 0.05 | -0.02 | -0.05 | -0.16 | -0.12 | -0.07 | -0.15 | -0.18 |
| Diluted Shares Outstanding | 314.36M | 310.43M | 308.25M | 307.69M | 299.04M | 304.69M | 303.77M | 302.9M | 293.59M | 295.76M | 292.8M | 291.34M |
| Basic Shares Outstanding | 309.03M | 308.47M | 308.25M | 307.69M | 299.04M | 304.69M | 303.77M | 302.9M | 293.59M | 295.76M | 292.8M | 291.34M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |